Claris Lifesciences Ltd vs Divi's Laboratories Limited

A side-by-side comparison of Claris Lifesciences Ltd (533288) and Divi's Laboratories Limited (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads 533288 vs DIVISLAB on 9 of 14 metrics (3 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable—
  • Size & financial health03

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
94.52
0.00
P/B ratio
14.90
0.00%
Dividend yield
0.32%
₹-0.05
EPS
₹96.75

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
15.32%
-2.85%
Return on capital
20.35%
-18034.00%
EBITDA margin
32.59%
-15850.00%
Net margin
24.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
10.78%
—
Profit CAGR (3Y) even
12.09%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹2.45L Cr
₹0 Cr
Revenue
₹10,560 Cr
₹-0 Cr
Net profit
₹2,568 Cr
0.00
Debt / equity even
0.00
Claris Lifesciences Ltd
  • − ["Company has low interest coverage ratio."]
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Claris Lifesciences Ltd full analysis Divi's Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

533288 vs DIVISLAB: Share Price, Valuation & Which to Buy | DocStoX